Brief: POINT Biopharma Confirms No Supply Shortages Of 177177LU-PNT002 For The Splash Trial
May 5 (Reuters) - POINT Biopharma Global Inc PNT.O :
* POINT BIOPHARMA CONFIRMS NO SUPPLY SHORTAGES OF
177LU-PNT2002
FOR THE SPLASH TRIAL
* POINT BIOPHARMA GLOBAL INC - AFFIRMED THAT SPLASH CLINICAL
TRIAL
FOR PSMA TARGETED (177)LU-PNT2002 PROGRAM REMAINS ON SCHEDULE
Source text for Eikon: ID:nGNX51JQ10
Further company coverage: PNT.O
Recent news on POINT Biopharma Global
See all newsBrief: Eli Lilly Completes Acquisition Of POINT Biopharma
Fusion Pharma gains on Bristol Myers-RayzeBio deal
Brief: Point Biopharma- Lilly Offer Expired And Not Further Extended - SEC Filing
Brief: BVF Partners Dissolves Share Stake In Point Biopharma Global
U.S. STOCKS ON THE MOVE-Biomerica, Netflix, SunPower